Ratiopharm News
Most Popular Ratiopharm Story
Is Pfizer still in the Ratiopharm race?
There's some news on the Ratiopharm deal that fills in some details--and throws others into question. Sources tell Dow Jones that the company will decide next week which two prospective buyers will Read more...
Latest Headlines
- July 27, 2011
- June 23, 2010
- May 10, 2010
- March 19, 2010
- March 18, 2010
- March 17, 2010
- March 9, 2010
- March 8, 2010
- March 3, 2010
- February 18, 2010
- February 17, 2010
- February 11, 2010
- February 3, 2010
- February 1, 2010
- January 19, 2010
- December 24, 2009
- December 22, 2009
- December 11, 2009
- December 4, 2009
- November 30, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
